SCHEMBL23940768

SCHEMBL23940768

CCOC(=O)c1c(C)c(O)c(C(C)(C)C)c(CC)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
NPSR1 Q6W5P4 3/20 0.50
KDM4E B2RXH2 3/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
ADORA3 P0DMS8 7/20 0.48
TDP1 Q9NUW8 1/20 0.46
GRM6 O15303 3/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 2/20 0.43
POLB P06746 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25144993 0.91 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23940769 0.86 MAPT (0.56) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23940776 0.85 MAPT (0.50) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23941182 0.81 MAPT (0.56) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23941036 0.73 MAPT (0.56) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23926181 0.72 MAPT (0.55) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL27574556 0.71 MAPT (0.48) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL27933356 0.71 ALDH1A1 (0.61) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23940967 0.71 ALDH1A1 (0.50) MAPTALDH1A1HPGDSMN1; SMN2NPSR1
SCHEMBL23925845 0.70 ADORA3 (0.50) MAPTALDH1A1HPGDSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2023-04-20 US disclosed
WO-2021211982-A2 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS OREGON STATE UNIVERSITY (US) 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117370-A1 REGIOSELECTIVE SYNTHESIS OF SUBSTITUTED COMPOUNDS CYP2B6, TYR, CYP2D6 MAPT 4814/4885ALDH1A1 88/4885HPGD 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.